How has Integra LifeSciences's research and development expense changed year-over-year?

Integra LifeSciences's research and development expense decreased by 5.0% year-over-year, from $24.73M to $23.5M.

What is the long-term trend for Integra LifeSciences's research and development expense?

Over 4 years (2021 to 2025), Integra LifeSciences's research and development expense has grown at a 1.6% compound annual growth rate (CAGR), from $93.05M to $98.97M.

Integra LifeSciences IART Research and development expense

Research and development expense at other companies

Boston ScientificBSX

$516M+16.5%

AbbVieABBV

——

MedtronicMDT

——

ITG

Integer HoldingsITGR

——

Merit Medical SystemsMMSI

——

Segments

By segment

See full

Specialty Surgery$11.85M—

Tissue Reconstruction$7.53M—

Other financials

Income statement

See full

Revenue$391.9M+2.4%

Gross profit$217.0M+11.6%

Operating income$11.5M+174%

Net income-$4.6M+81.7%

EPS (diluted)-$0.06+81.8%

Balance sheet

See full

Cash & equivalents$236.8M-1.0%

Total debt$2.0B+3.2%

Total equity$1.0B-31.6%

Total assets$3.6B-11.7%

Cash flow

See full

Operating cash flow$9.8M+187%

CapEx$14.8M-48.7%

Free cash flow-$5.0M+87.4%

Valuation

See full

Market cap$1.38B+53.4%

Enterprise value$3.12B+21.1%

P/S0.8×+0.3×

Profitability

See full

Gross margin51.9%-1.6pp

Operating margin-29.8%-30.3pp

Net margin-30.1%—

FCF margin3.8%-6.3pp

Returns & leverage

See full

Return on equity-38.6%—

Debt / equity1.9×+0.6×

Current ratio3.4×+2.2×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's research and development expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Integra LifeSciences's research and development expense?: Integra LifeSciences (IART) reported research and development expense of $23.5M in Q1 2026.
How has Integra LifeSciences's research and development expense changed year-over-year?: Integra LifeSciences's research and development expense decreased by 5.0% year-over-year, from $24.73M to $23.5M.
What is the long-term trend for Integra LifeSciences's research and development expense?: Over 4 years (2021 to 2025), Integra LifeSciences's research and development expense has grown at a 1.6% compound annual growth rate (CAGR), from $93.05M to $98.97M.